J. Jordan

Perspectives on Adherence and Simplicity for HIV-Infected Patients on Antiretroviral Therapy: Self-Report of the Relative Importance of Multiple Attributes of Highly Active Antiretroviral Therapy (HAART) Regimens in Predicting Adherence

J. Tolson, V. Stone, J. Jordan, 2004, Journal of acquired immune deficiency syndromes.

Adherence to combined Lamivudine+Zidovudine versus individual components: A community-based retrospective medicaid claims analysis

J. Jordan, J. Rosenzweig, A Legorreta, 2005, AIDS care.

Abacavir compared to protease inhibitors as part of HAART regimens for treatment of HIV infection: patient satisfaction and implications for adherence.

F. Goebel, P. Cahn, J. Jordan, 2005, AIDS patient care and STDs.

Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)

A. Vibhagool, P. Cahn, J. Jordan, 2004, Current medical research and opinion.

Suppressive Valacyclovir Therapy: Impact on the Population Spread of HSV-2 Infection

G. Garnett, J. Jordan, John R. Williams, 2007, Sexually transmitted diseases.

Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine

A. Vibhagool, P. Cahn, J. Jordan, 2004, Current medical research and opinion.

Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States

J. Jordan, S. Fehnel, R. V. Clark, 2008, Climacteric.